Celgene Corp. CELG, +0.73% shares rose 1.4% in Thursday premarket trade after the company reported second-quarter profit and revenue beats and upbeat 2018 guidance.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,